Capillary and Venous Blood Sampling Devices Market Analysis

Capillary and Venous Blood Sampling Devices Segmentation

Product (Capillary Blood Collection Devices, Venous Blood Collection Devices)

The capillary and venous blood sampling devices market from venous blood sampling devices segment is estimated to gain the largest market share of USD 7,836.6 million over the projected time frame. The segment's expansion can be attributable to the vast number of clinical trials with HSV-based viruses that are now underway.  Thus, the main venous blood collection devices are tubes and vacutainer systems used for cancer, HIV/AIDS, and other blood testing which are fueling the expansion of the venous blood collection devices segment in the market. Furthermore, veins are favored over arteries and capillaries as they have thinner walls, and thus they are easier to puncture.

Device (Point-of-Care Testing, Central Testing)

Out of devices of capillary and venous blood sampling devices, the central testing segment is predicted to have a tremendous share in the upcoming years as the majority of blood tests are performed in the laboratories by different methods in order to result more accurate. They can process a large number of samples with high efficiency and automation, requiring less manual assistance.  For instance, in 2021, among the more than 320,000 federally licensed laboratories in the United States, there were more than 329,000 laboratory specialists employed. In addition to the roughly 1 billion COVID-19 tests performed during the epidemic, an estimated 14 billion laboratory tests are ordered annually in the United States.

Our in-depth analysis of the market includes the following segments: